MAPT and Alzheimer disease: Previous studies demonstrated that relative to late-onset AD, early-onset AD exhibits more extensive pathological and neurodegenerative changes with respect to (among others) amyloid, metabolic activity [7, 46], atrophy [47, 48], functional network changes [49–51], and tau [52, 53].